Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.58 |
| ▸ | KDM6B | O15054 | 1/20 | 0.58 |
| ▸ | KDM5C | P41229 | 1/20 | 0.58 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.58 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.58 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.58 |
| ▸ | MGAM | O43451 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | SI | P14410 | 1/20 | 0.50 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | MMP12 | P39900 | 1/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3519320 | 0.96 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28706026 | 0.96 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL10936077 | 0.96 | KDM4E (0.55) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28634328 | 0.93 | KDM4E (0.52) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL28887 | 0.87 | EGLN1 (0.62) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL321597 | 0.87 | EGLN1 (0.62) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL61062 | 0.85 | KDM4E (0.78) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL23777918 | 0.84 | KDM4E (0.46) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL10564199 | 0.84 | KDM4E (0.46) | KDM4EKDM6BKDM5CEGLN1PHF8 | |
| SCHEMBL16518799 | 0.84 | KDM4E (0.46) | KDM4EKDM6BKDM5CEGLN1PHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 682 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118496812-A | Preparation method of low-compression set single-component addition type liquid silicone rubber for CIPG (copper-in-place) process | 广州天宸高新材料有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-118307001-A | Method for preparing high-magnification silicon-based composite anode material by utilizing photovoltaic silicon cutting waste | 昆明理工大学 | 2024-07-09 | — | — | CN | claimed |
| CN-113710718-B | Stabilized silane-modified polymer compositions and methods | 迈图高新材料公司 | 2024-06-25 | — | — | CN | claimed |
| EP-4043610-B1 | METAL SURFACE-TREATING AGENT, AND METAL MATERIAL WITH COATING FILM AND METHOD FOR MANUFACTURING SAME | NIHON PARKERIZING (JP) | 2024-05-29 | — | — | EP | claimed |
| CN-113908833-B | Reverse water gas shift catalyst and preparation method and application thereof | 源创核新(北京)新材料科技有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-116554372-A | Preparation method of low-entanglement ultra-high molecular weight polyethylene | 中国科学院长春应用化学研究所 | 2023-08-08 | — | — | CN | claimed |
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PSOMAGEN, INC. (US) | 2022-08-23 | — | — | US | claimed |
| EP-4012395-A1 | FREE-FLOW ELECTROPHORESIS METHOD FOR SEPARATING ANALYTES | Weber, Gerhard (DE) | 2022-06-15 | — | — | EP | claimed |
| CN-113908833-A | Reverse water gas shift catalyst and preparation method and application thereof | 源创核新(北京)新材料科技有限公司 | 2022-01-11 | — | — | CN | claimed |
| CN-113278004-A | Preparation method of aliphatic cyclic polycarbonate | 源创核新(北京)新材料科技有限公司 | 2021-08-20 | — | — | CN | claimed |
| EP-1164633-A2 | Method for etching an electrode in a semiconductor device | NEC CORPORATION (JP) | 2001-12-19 | — | — | EP | claimed |
| EP-0907762-B1 | CHROMATE-FREE CONVERSION LAYER AND PROCESS FOR PRODUCING THE SAME | SURTEC PRODUKTE UND SYSTEME FU (DE) | 2001-10-17 | — | — | EP | claimed |
| US-5877210-A | CONTROLLING IMMUNE RESPONSE | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-03-02 | — | — | US | claimed |
| US-5858386-A | CONTROLLED RELEASE OF BIOACTIVE AGENTS ON DRY PRE-FLOODED LAND; WATER SOLUBLE, BIODEGRADABLE COATING OF FATTY ALCOHOLS, FATTY ACIDS, FATTY ESTERS OR PHTHALYL ESTERS; MOSQUITO, WEED CONTROL; NO SUPERABSORBENT POLYMERS | LEE COUNTY MOSQUITO CONTROL DISTRICT (US) | 1999-01-12 | — | — | US | claimed |
| US-5858384-A | Controlled delivery compositions and processes for treating organisms in a column of water or on land | LEE COUNTY MOSQUITO CONTROL DISTRICT (US) | 1999-01-12 | — | — | US | claimed |
| US-5846553-A | Controlled delivery compositions and processes for treating organisms in a column of water or on land | LEE COUNTY MOSQUITO CONTROL DISTRICT (US) | 1998-12-08 | — | — | US | claimed |
| US-5583242-A | VANADYL COMPLEXES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-12-10 | — | — | US | claimed |
| US-5565491-A | FOR TREATMENT OF DISEASES MARKED BY MALIGNANT PROLIFERATION OF B CELLS, SUCH AS LEUKEMIA AND LYMPHOMAS; ANTICARCINOGENIC AGENTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1996-10-15 | — | — | US | claimed |
| US-5091591-A | Ammonium, alkali, alkaline earth metal or zinc salt of aliphatic mono ro dicarboxalic acid as stabilizers | GENERAL ELECTRIC COMPANY (US) | 1992-02-25 | — | — | US | claimed |
| EP-0470898-A1 | Piezoelectric ceramic with controlled porosity | THOMSON-CSF (FR) | 1992-02-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PNMT, MAOA, HNMT | KDM4E 733/4885KDM6B 565/4885KDM5C 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.